PRF Technologies (PRFX) Total Current Liabilities (2019 - 2025)
PRF Technologies' (PRFX) quarterly Total Current Liabilities came in at $2.4 million in Q4 2025, little changed YoY from $2.4 million in Q4 2024, and down 0.61% on a QoQ basis from $2.5 million in Q2 2025.
PRF Technologies (PRFX) Total Current Liabilities (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 7 years of Total Current Liabilities data on file, last reported at $2.4 million in Q4 2025.
- Quarterly Total Current Liabilities changed 0.04% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (changed 0.04% YoY) and the FY2025 annual result came in at $2.4 million, changed 0.04% from the prior year.
- Total Current Liabilities retreated to $2.4 million in Q4 2025, from $2.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $4.9 million in Q2 2024 to a low of $549000.0 in Q2 2022.
- A 5-year average of $1.5 million and a median of $1.1 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities sank 91.08% — and 2024, when it surged 346.26%.
- Tracing PRFX's Total Current Liabilities over 5 years: stood at $757000.0 in 2021, then surged by 40.55% to $1.1 million in 2022, then plunged by 37.5% to $665000.0 in 2023, then surged by 267.22% to $2.4 million in 2024, then dropped by 0.04% to $2.4 million in 2025.
- The last three Total Current Liabilities figures came in at $2.4 million (Q4 2025), $2.5 million (Q2 2025), and $2.4 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.44 Mn |
| Jun 30, 2025 | 2.46 Mn |
| Dec 31, 2024 | 2.44 Mn |
| Jun 30, 2024 | 4.89 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 665,000.00 |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.28 Mn |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 1.19 Mn |
| Jun 30, 2022 | 549,000.00 |
| Mar 31, 2022 | 768,000.00 |
| Dec 31, 2021 | 757,000.00 |
| Sep 30, 2021 | 628,000.00 |
| Jun 30, 2021 | 613,000.00 |
| Mar 31, 2021 | 741,000.00 |
| Dec 31, 2020 | 961,000.00 |
| Jun 30, 2020 | 6.87 Mn |
| Dec 31, 2019 | 6.34 Mn |